Strategic Reporting Through Counterpoised Disclosure: Evidence From the Biopharma IndustryStratégie de divulgation basée sur la communication d'information compensatoire : données issues de l'industrie biopharmaceutique
Luminita Enache, Lynn Li, Edward J. Riedl, Scarlett (Xiaotong) Song. Strategic Reporting Through Counterpoised Disclosure: Evidence From the Biopharma IndustryStratégie de divulgation basée sur la communication d'information compensatoire : données issues de l'industrie biopharmaceutique. // Contemporary Accounting Research. – 2026. – DOI: 10.1111/1911-3846.70078. – URL: https://onlinelibrary.wiley.com/doi/10.1111/1911-3846.70078?af=R
Luminita Enache, Lynn Li, Edward J. Riedl, & Scarlett (Xiaotong) Song (2026). Strategic Reporting Through Counterpoised Disclosure: Evidence From the Biopharma IndustryStratégie de divulgation basée sur la communication d'information compensatoire : données issues de l'industrie biopharmaceutique. Contemporary Accounting Research. https://doi.org/10.1111/1911-3846.70078
Luminita Enache, et al. “Strategic Reporting Through Counterpoised Disclosure: Evidence From the Biopharma IndustryStratégie de divulgation basée sur la communication d'information compensatoire : données issues de l'industrie biopharmaceutique.” Contemporary Accounting Research, 2026. doi:10.1111/1911-3846.70078.
@article{Enache2026,
title = {Strategic Reporting Through Counterpoised Disclosure: Evidence From the Biopharma IndustryStratégie de divulgation basée sur la communication d'information compensatoire : données issues de l'industrie biopharmaceutique},
author = {Enache, Luminita and Li, Lynn and Riedl, Edward J. and Song, Scarlett (Xiaotong)},
journal = {Contemporary Accounting Research},
year = {2026},
doi = {10.1111/1911-3846.70078},
url = {https://onlinelibrary.wiley.com/doi/10.1111/1911-3846.70078?af=R}
}